Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Compared to other primates, humans are exceptional long-distance runners, a feature that emerged in genus
Homo
approximately 2 Ma and is classically attributed to anatomical and physiological adaptations such as an enlarged gluteus maximus and improved heat dissipation. However, no underlying genetic changes have currently been defined. Two to three million years ago, an exon deletion in the
CMP-Neu5Ac hydroxylase
(
CMAH
) gene also became fixed in our ancestral lineage.
Cmah
loss in mice exacerbates disease severity in multiple mouse models for
muscular dystrophy
, a finding only partially attributed to differences in immune reactivity. We evaluated the exercise capacity of
Cmah
-/-
mice and observed an increased performance during forced treadmill testing and after 15 days of voluntary wheel running.
Cmah
-/-
hindlimb muscle exhibited more capillaries and a greater fatigue resistance
in situ
Maximal coupled respiration was also higher in
Cmah
null mice
ex vivo
and relevant differences in metabolic pathways were also noted. Taken together, these data suggest that
CMAH
loss contributes to an improved skeletal muscle capacity for oxygen use. If translatable to humans,
CMAH
loss could have provided a selective advantage for ancestral
Homo
during the transition from forest dwelling to increased resource exploration and hunter/gatherer behaviour in the open savannah.
...
PMID:Human-like Cmah inactivation in mice increases running endurance and decreases muscle fatigability: implications for human evolution. 3020 32